• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Miromatrix Medical Inc. (MIRO) Stock Price, News & Analysis

Miromatrix Medical Inc. (MIRO) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$3.36
Day's range
$3.53
50-day range
$0.9603
Day's range
$3.53
  • Country: US
  • ISIN: US60471P1084
52 wk range
$0.91
Day's range
$4.35
  • CEO: Dr. Jeffrey James Ross Ph.D.
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -3.66
  • Piotroski Score 3.00
  • Grade Overweight
  • Symbol (MIRO)
  • Company Miromatrix Medical Inc.
  • Price $3.39
  • Changes Percentage (0.59%)
  • Change $0.02
  • Day Low $3.36
  • Day High $3.53
  • Year High $4.35

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/28/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $9.00
  • High Stock Price Target $9.00
  • Low Stock Price Target $9.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.14
  • Trailing P/E Ratio -2.9736842105263
  • Forward P/E Ratio -2.9736842105263
  • P/E Growth -2.9736842105263
  • Net Income $-30,007,832

Income Statement

Quarterly

Annual

Latest News of MIRO

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Miromatrix Medical Inc. Frequently Asked Questions

  • What is the Miromatrix Medical Inc. stock price today?

    Today's price of Miromatrix Medical Inc. is $3.39 — it has increased by +0.59% in the past 24 hours. Watch Miromatrix Medical Inc. stock price performance more closely on the chart.

  • Does Miromatrix Medical Inc. release reports?

    Yes, you can track Miromatrix Medical Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Miromatrix Medical Inc. stock forecast?

    Watch the Miromatrix Medical Inc. chart and read a more detailed Miromatrix Medical Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Miromatrix Medical Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Miromatrix Medical Inc. stock ticker.

  • How to buy Miromatrix Medical Inc. stocks?

    Like other stocks, MIRO shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Miromatrix Medical Inc.'s EBITDA?

    Miromatrix Medical Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Miromatrix Medical Inc.’s financial statements.

  • What is the Miromatrix Medical Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is -31.4722350992, which equates to approximately -3,147.22%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Miromatrix Medical Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Miromatrix Medical Inc.'s financials relevant news, and technical analysis. Miromatrix Medical Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Miromatrix Medical Inc. stock currently indicates a “sell” signal. For more insights, review Miromatrix Medical Inc.’s technical analysis.

  • A revenue figure for Miromatrix Medical Inc. for its last quarter?

    Miromatrix Medical Inc. published it's last quarterly revenues at $11,176.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.